Atlas FDA

LINX Reflux Management System

FDA premarket approval P100049/S027 · decided 2020-06-29

Approval details

PMA number
P100049
Supplement
S027
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
LINX Reflux Management System
Generic name
IMPLANT, ANTI-GASTROESOPHAGEAL REFLUX
Applicant
Torax Medical
Date received
2019-09-17
Decision date
2020-06-29
Days to decision
286 days
Decision code
APPR
Product code
LEI
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Cincinnati, OH
Statement
adding a second Hardwell Controlled Environmental Area (CEA).

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.